Indian Sucrose (500319)
CyclicalScore breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹111.6 |
| Market Cap | ₹198.05 Cr |
| P/E Ratio | 3.11 |
| ROCE | 17.41% |
| ROE | 19.18% |
| Dividend Yield | 0% |
| Profit Growth | 135.31% |
| Debt/Equity | — |
| Sales Growth | 54.3% |
| 52-Week Range | ₹61.31 — ₹111.6 |
| Sector | Agricultural Food & other Products |
| Book Value | ₹126.62 |
Strengths
- P/E of 3.11 and P/B of 0.88 suggest the stock trades below book value, offering a Margin of Safety if the balance sheet is sound.
- ROE of 19.18% and ROCE of 17.41% indicate efficient capital use during the current upcycle.
- Piotroski F-Score of 7/9 points to broadly improving financial health and earnings quality.
- Sales growth of 54.30% and profit growth of 135.31% show strong near-term momentum, though this is likely cyclical.
Concerns
- Sugar is a commodity business with no pricing power or durable moat; current high profits are probably at a cyclical peak.
- Zero dividend yield means the investor depends entirely on capital appreciation and eventual exit at a better price.
- Debt-to-equity and promoter holding are not disclosed, so leverage and governance cannot be properly assessed.
- Latest quarter net profit of ₹7 crore on sales of ₹80 crore suggests normalised earnings may be far below trailing P/E levels.
AI Analysis
At first glance, Indian Sucrose looks like a bargain hunter's dream: a P/E of 3.11, a share price of ₹111.60 against a book value of ₹126.62, and a return on equity of 19.18%. But Benjamin Graham taught me that a low multiple is not an invitation; it is a starting point for questions. This is a sugar company, and sugar is a commodity. There is no brand, no pricing power, no durable moat. When sugar prices are high, profits surge; when they turn, earnings can vanish. The 54.30% sales growth and 135.31% profit growth are impressive, but they shout 'cyclical peak' far more than 'competitive excellence.' A PEG of 0.03 assumes the growth will persist, and that is a dangerous assumption in this industry. The Piotroski F-Score of 7 does suggest decent financial health, and ROCE of 17.41% is respectable. Buying below book value provides some margin of safety, but only if the book value is solid and not inflated by leverage. Unfortunately, debt-to-equity is not disclosed, promoter holding is not available, and the dividend yield is zero. I cannot praise a business I cannot fully see. If sugar prices decline, today's cheap earnings could become tomorrow's expensive losses. The latest quarter's net profit of ₹7 crore on sales of ₹80 crore would not justify a high multiple. This looks like a cyclical opportunity, not a franchise. I would only consider it with a wide margin of safety, a clean balance sheet, and a clear view on sugar prices. Otherwise, I pass.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer